• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

翻译后修饰如何影响亨廷顿舞蹈症的病理机制格局?一项综合综述。

How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.

机构信息

Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

MTA-DE Cell Biology and Signaling Research Group, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

出版信息

Int J Mol Sci. 2020 Jun 16;21(12):4282. doi: 10.3390/ijms21124282.

DOI:10.3390/ijms21124282
PMID:32560122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7349273/
Abstract

Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disorder characterized by the loss of motor control and cognitive ability, which eventually leads to death. The mutant huntingtin protein (HTT) exhibits an expansion of a polyglutamine repeat. The mechanism of pathogenesis is still not fully characterized; however, evidence suggests that post-translational modifications (PTMs) of HTT and upstream and downstream proteins of neuronal signaling pathways are involved. The determination and characterization of PTMs are essential to understand the mechanisms at work in HD, to define possible therapeutic targets better, and to challenge the scientific community to develop new approaches and methods. The discovery and characterization of a panoply of PTMs in HTT aggregation and cellular events in HD will bring us closer to understanding how the expression of mutant polyglutamine-containing HTT affects cellular homeostasis that leads to the perturbation of cell functions, neurotoxicity, and finally, cell death. Hence, here we review the current knowledge on recently identified PTMs of HD-related proteins and their pathophysiological relevance in the formation of abnormal protein aggregates, proteolytic dysfunction, and alterations of mitochondrial and metabolic pathways, neuroinflammatory regulation, excitotoxicity, and abnormal regulation of gene expression.

摘要

亨廷顿舞蹈症(HD)是一种常染色体显性遗传的神经退行性疾病,其特征为运动控制和认知能力丧失,最终导致死亡。突变的亨廷顿蛋白(HTT)表现出多聚谷氨酰胺重复序列的扩增。发病机制尚未完全明确;然而,有证据表明HTT的翻译后修饰(PTM)以及神经信号通路的上下游蛋白都参与其中。PTM的确定和表征对于理解HD的发病机制、更好地定义可能的治疗靶点以及促使科学界开发新的方法至关重要。在HTT聚集和HD细胞事件中发现并表征一系列PTM,将使我们更接近了解含多聚谷氨酰胺突变的HTT表达如何影响细胞稳态,进而导致细胞功能紊乱、神经毒性并最终导致细胞死亡。因此,在此我们综述了目前关于HD相关蛋白最近鉴定出的PTM及其在异常蛋白聚集体形成、蛋白水解功能障碍、线粒体和代谢途径改变、神经炎症调节、兴奋性毒性以及基因表达异常调节中的病理生理相关性的知识。

相似文献

1
How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.翻译后修饰如何影响亨廷顿舞蹈症的病理机制格局?一项综合综述。
Int J Mol Sci. 2020 Jun 16;21(12):4282. doi: 10.3390/ijms21124282.
2
Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.蛋白水解结构域内的翻译后修饰聚类可降低突变型亨廷顿蛋白的毒性。
J Biol Chem. 2017 Nov 24;292(47):19238-19249. doi: 10.1074/jbc.M117.782300. Epub 2017 Sep 27.
3
Proteostasis of Huntingtin in Health and Disease.亨廷顿蛋白在健康与疾病中的蛋白质稳态
Int J Mol Sci. 2017 Jul 19;18(7):1568. doi: 10.3390/ijms18071568.
4
The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.亨廷顿舞蹈症细胞模型中早期转录变化和聚集体形成的动力学
BMC Genomics. 2017 May 12;18(1):373. doi: 10.1186/s12864-017-3745-z.
5
A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease.一种人类亨廷顿蛋白单核苷酸多态性改变了该蛋白的翻译后修饰和致病性蛋白水解,从而导致亨廷顿病。
Sci Rep. 2018 May 25;8(1):8096. doi: 10.1038/s41598-018-25903-w.
6
Protective Proteolysis in Huntington's Disease: Unraveling the Role of Post-Translational Myristoylation of Huntingtin in Autophagy.亨廷顿病中的保护蛋白水解:解析亨廷顿蛋白翻译后豆蔻酰化在自噬中的作用。
J Huntingtons Dis. 2024;13(3):267-277. doi: 10.3233/JHD-240028.
7
Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.翻译结果:内源性亨廷顿蛋白上鉴定的翻译后修饰(PTMs)簇集在热重复区之间的蛋白水解结构域内。
J Proteome Res. 2017 Aug 4;16(8):2692-2708. doi: 10.1021/acs.jproteome.6b00991. Epub 2017 Jul 3.
8
Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance.鉴定亨廷顿蛋白中一个新的半胱天冬酶剪切位点,该位点调节突变型亨廷顿蛋白的清除。
FASEB J. 2019 Mar;33(3):3190-3197. doi: 10.1096/fj.201701510RRR. Epub 2018 Nov 13.
9
The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.亨廷顿病中突变型亨廷顿蛋白-蛋白相互作用失调的病理生物学。
J Neurochem. 2019 Nov;151(4):507-519. doi: 10.1111/jnc.14853. Epub 2019 Sep 15.
10
Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.致病性亨廷顿蛋白通过内体区室的局部破坏改变骨形态发生蛋白信号传导和突触生长。
J Neurosci. 2017 Mar 22;37(12):3425-3439. doi: 10.1523/JNEUROSCI.2752-16.2017. Epub 2017 Feb 24.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Evidence based molecular pathways, available drug targets, pre- clinical animal models and future disease modifying treatments of huntington's disease.亨廷顿舞蹈症的循证分子途径、可用药物靶点、临床前动物模型及未来疾病修饰治疗
Mol Biol Rep. 2025 Jul 25;52(1):754. doi: 10.1007/s11033-025-10852-1.
3
Baicalein-mediated regulation of Nrf2/ARE, NFĸB, and MAPK signaling in Huntington's disease: a promising strategy against neuroinflammation and neurodegeneration.

本文引用的文献

1
Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review.翻译后修饰是否影响神经退行性疾病中的蛋白质聚集:一项系统综述。
Brain Sci. 2020 Apr 11;10(4):232. doi: 10.3390/brainsci10040232.
2
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's disease.Nemo 样激酶降低突变型亨廷顿蛋白水平并减轻亨廷顿病。
Hum Mol Genet. 2020 May 28;29(8):1340-1352. doi: 10.1093/hmg/ddaa061.
3
SUMOylation in development and neurodegeneration.SUMOylation 在发育和神经退行性变中的作用。
黄芩素介导的对亨廷顿舞蹈病中Nrf2/ARE、NFκB和MAPK信号通路的调控:一种对抗神经炎症和神经退行性变的有前景的策略。
Inflammopharmacology. 2025 Jul 5. doi: 10.1007/s10787-025-01839-2.
4
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.针对亨廷顿病的衰老和细胞衰老的治疗方法。
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
5
Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration.多聚谷氨酰胺(PolyQ)疾病:探索神经退行性变的全景。
ACS Chem Neurosci. 2024 Aug 7;15(15):2665-2694. doi: 10.1021/acschemneuro.4c00184. Epub 2024 Jul 12.
6
Protective Proteolysis in Huntington's Disease: Unraveling the Role of Post-Translational Myristoylation of Huntingtin in Autophagy.亨廷顿病中的保护蛋白水解:解析亨廷顿蛋白翻译后豆蔻酰化在自噬中的作用。
J Huntingtons Dis. 2024;13(3):267-277. doi: 10.3233/JHD-240028.
7
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.微小RNA生物标志物作为神经退行性疾病的下一代诊断工具:综述
Front Mol Neurosci. 2024 May 31;17:1386735. doi: 10.3389/fnmol.2024.1386735. eCollection 2024.
8
Molecular Role of Protein Phosphatases in Alzheimer's and Other Neurodegenerative Diseases.蛋白磷酸酶在阿尔茨海默病及其他神经退行性疾病中的分子作用
Biomedicines. 2024 May 15;12(5):1097. doi: 10.3390/biomedicines12051097.
9
HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases.组蛋白乙酰转移酶和组蛋白去乙酰化酶:在神经退行性疾病中具有相反作用的酶
Mol Neurobiol. 2024 Nov;61(11):9110-9124. doi: 10.1007/s12035-024-04115-6. Epub 2024 Apr 8.
10
A Comprehensive Bioinformatics Approach to Identify Molecular Signatures and Key Pathways for the Huntington Disease.一种用于识别亨廷顿病分子特征和关键通路的综合生物信息学方法。
Bioinform Biol Insights. 2023 Nov 27;17:11779322231210098. doi: 10.1177/11779322231210098. eCollection 2023.
Development. 2020 Mar 18;147(6):dev175703. doi: 10.1242/dev.175703.
4
Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders.远不止是支架:细胞骨架蛋白与神经疾病。
Cells. 2020 Feb 4;9(2):358. doi: 10.3390/cells9020358.
5
Dynamic Interaction of USP14 with the Chaperone HSC70 Mediates Crosstalk between the Proteasome, ER Signaling, and Autophagy.泛素特异性蛋白酶14(USP14)与伴侣蛋白HSC70的动态相互作用介导蛋白酶体、内质网信号和自噬之间的串扰。
iScience. 2020 Jan 24;23(1):100790. doi: 10.1016/j.isci.2019.100790. Epub 2019 Dec 19.
6
Huntington's Disease Pathogenesis Is Modified In Vivo by Alfy/Wdfy3 and Selective Macroautophagy.亨廷顿病的发病机制可被 Alfy/Wdfy3 和选择性巨自噬在体内改变。
Neuron. 2020 Mar 4;105(5):813-821.e6. doi: 10.1016/j.neuron.2019.12.003. Epub 2019 Dec 30.
7
SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes.SUMOylation 可防止亨廷顿蛋白纤维形成并定位于脂膜。
ACS Chem Neurosci. 2020 Feb 5;11(3):328-343. doi: 10.1021/acschemneuro.9b00509. Epub 2020 Jan 9.
8
Molecular mechanisms in SUMO conjugation.SUMO 连接中的分子机制。
Biochem Soc Trans. 2020 Feb 28;48(1):123-135. doi: 10.1042/BST20190357.
9
Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.神经退行性疾病和急性脑损伤的表观遗传机制。
Neurochem Int. 2020 Feb;133:104642. doi: 10.1016/j.neuint.2019.104642. Epub 2019 Dec 12.
10
TRPC5 channel instability induced by depalmitoylation protects striatal neurons against oxidative stress in Huntington's disease.去棕榈酰化诱导的 TRPC5 通道不稳定性可保护亨廷顿病纹状体神经元免受氧化应激。
Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118620. doi: 10.1016/j.bbamcr.2019.118620. Epub 2019 Dec 6.